Ampersand 2018 Limited Partnership 13D and 13G filings for Interpace Biosciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-10-16 4:30 pm Purchase | 2024-10-11 | 13D | Interpace Biosciences, Inc. IDXG | Ampersand 2018 Limited Partnership | 13,861,386 76.000% | 9,194,720 (+197.03%) | Filing |
| 2021-11-12 4:31 pm Unchanged | 2021-11-01 | 13D | Interpace Biosciences, Inc. IDXG | Ampersand 2018 Limited Partnership | 4,666,666 38.900% | 0 (Unchanged) | Filing |
| 2021-05-18 5:01 pm Unchanged | 2021-05-10 | 13D | Interpace Biosciences, Inc. IDXG | Ampersand 2018 Limited Partnership | 4,666,666 39.100% | 0 (Unchanged) | Filing |
| 2021-01-19 4:13 pm Unchanged | 2021-01-07 | 13D | Interpace Biosciences, Inc. IDXG | Ampersand 2018 Limited Partnership | 4,666,666 39.300% | 0 (Unchanged) | Filing |
| 2020-04-22 5:40 pm Unchanged | 2020-04-07 | 13D | Interpace Biosciences, Inc. IDXG | Ampersand 2018 Limited Partnership | 4,666,666 39.300% | 0 (Unchanged) | Filing |